Iovance Biotherapeutics recently announced that its tumor-infiltrating lymphocyte (TIL) therapy for soft tissue sarcoma has achieved positive results in its first clinical trial.
Show original
Bitget offers one-stop trading for cryptocurrencies, stocks, and gold. Trade now!
A welcome pack worth 6200 USDT for new users! Sign up now!
This groundbreaking development marks a key step forward for TIL cell therapy in the treatment of solid tumors, bringing new hope for patients with soft tissue sarcoma.
0
0
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
Understand the market, then trade.
Bitget offers one-stop trading for cryptocurrencies, stocks, and gold.
Trade now！
You may also like
Circle completes $222 million ARC token presale with a valuation of $3 billion
ForesightNews•2026/05/11 10:29
Circle’s Q1 revenue reaches $694 million, USDC on-chain transaction volume increases by 263% year-over-year
Odaily星球日报•2026/05/11 10:29
Trending news
MoreCrypto prices
More
Bitcoin
BTC
$81,093.04
+0.40%
Ethereum
ETH
$2,336.41
+0.52%
Tether USDt
USDT
$0.9997
-0.00%
XRP
XRP
$1.45
+1.83%
BNB
BNB
$653.75
+0.56%
USDC
USDC
$0.9998
+0.00%
Solana
SOL
$95.46
+1.85%
TRON
TRX
$0.3508
+0.55%
Dogecoin
DOGE
$0.1101
+1.76%
Hyperliquid
HYPE
$41.98
-1.90%
How to buy BTC
Bitget lists BTC – Buy or sell BTC quickly on Bitget!
Trade now
Become a trader now?A welcome pack worth 6200 USDT for new users!
Sign up now